A phase II clinical research on Renzhu Jianwei granule in treating chronic atrophic gastritis (qi deficiency, blood stasis and hot depression syndrome)

Renzhu Jianwei granule in the treating of chronic atrophic gastritis (qi deficiency, blood stasis and hot depression syndrome): randomized, single-blinded and multi-centric clinical research

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002614

Enrollment

Unknown

Registered

2012-10-23

Start date

2005-12-19

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrophic gastritis

Interventions

clinical group:Renzhujianwei granule

control group:Weifuchun tablet

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. chronic atrophic gastritis confirmed via endoscopy and biopsy within one month prior to the trial; 2. the pattern of qi deficiency, blood stasis and heat constraint diagnosed Chinese medicine; 3. age of 18-65 years; 4. voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. age below 18 or above 65 years old; 2. gastric and duodenal ulcers; 3. severe hyperplasia of the stomach mucosa or malignant pathological changes; 4. severe primary diseases of heart, liver, kidney and blood systems, abnormal liver and kidney; function (ALT 1.5 timaes higher than normal value); 5. psychosis; 6. pregnancy or lactation (contraceptive methods should be taken for female subjects); 7. allergic constitution or allergy to experiment drugs (more than two or any component); 8. other factors determined inappropriate to be included.

Design outcomes

Primary

Measure	Time frame
biopsy;mucosal inflammatory change under the gastroscopy;	—

Secondary

Measure	Time frame
Traditional Chinese Medicine syndrome scoring;HP;	—

Countries

China

Contacts

Public ContactWang Changhong

General Hospital of Shenyang Miliary Region

wch239@126.com+86 024 28897620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026